What Is Microplasty Partial Knee Replacement?

Microplasty refers to a specific instrumentation system designed for the Oxford unicompartmental knee replacement, a partial knee procedure that resurfaces only the damaged compartment of the knee while leaving the healthy bone, cartilage, and ligaments intact. The term comes up most often in orthopedic settings where surgeons are performing minimally invasive partial knee arthroplasty, and the Microplasty instruments were developed to make that surgery less disruptive than earlier approaches. Understanding the procedure, who it suits, and how recovery works can help anyone facing the prospect of knee surgery sort through their options more clearly.

What the Microplasty Instrumentation Actually Does

A unicompartmental knee replacement, sometimes called a partial knee replacement, replaces only the worn-out portion of the knee joint. Most commonly, that damaged area is on the inner (medial) side. The Oxford unicompartmental knee replacement (UKR) is one of the most widely studied designs for this surgery, using a mobile-bearing implant that allows a small plastic insert to glide between metal surfaces on the femur and tibia, mimicking some of the knee’s natural movement.

The Microplasty instrumentation is the set of surgical tools and guides that allows the surgeon to perform this Oxford UKR through a smaller incision and with less bone removal than older instrument sets required. Rather than opening the knee widely to get a clear view, the Microplasty system uses guides and cutting blocks designed for a more targeted approach. This means less disruption to surrounding soft tissues, which can translate to a quicker early recovery. The instruments also aim to improve the accuracy of bone cuts and implant positioning, which matters for the long-term survival of the replacement.

It is worth noting that “microplasty” is not a different type of implant. The implant itself is the same Oxford mobile-bearing prosthesis. The Microplasty label refers specifically to the instruments and surgical technique used to put it in. Patients sometimes hear the term and assume it describes a newer or fundamentally different device, but the distinction is in the approach rather than the hardware.

Partial Versus Total Knee Replacement

The biggest question most people face when discussing any unicompartmental procedure is why not just replace the whole knee. Total knee replacement (TKR) removes the surfaces of all three compartments of the knee, even the ones that may still be healthy. It is the more common surgery overall and has well-established long-term results. But it also means more bone loss, a longer recovery, and a knee that, while functional, does not feel as natural as the original joint.

Partial knee replacement preserves the undamaged compartments and, critically, preserves the cruciate ligaments. An intact anterior cruciate ligament (ACL) is actually a prerequisite for the Oxford UKR; without it, the mobile bearing cannot function as designed. Keeping these ligaments means that patients who receive a partial replacement often report that the knee feels more like their own joint than patients who undergo total replacement. Range of motion tends to be better, and people are more likely to return to moderate recreational activities.

The trade-off is that partial replacement demands a more precise diagnosis. If the arthritis has spread beyond one compartment, if there is significant inflammatory arthritis, or if the ACL is deficient, the surgery will not work well and a total replacement is the better option. This is where patient selection becomes critical, and where the decision can go wrong if a surgeon tries to fit the wrong patient into a partial replacement.

Who Qualifies for the Procedure

The Oxford UKR with Microplasty instrumentation is indicated for patients with anteromedial osteoarthritis of the knee, a specific pattern of wear where the damage is concentrated on the inner front portion of the joint.¹ This pattern is actually quite common among people with knee osteoarthritis, though it often gets lumped in with more generalized arthritis when patients receive their diagnosis.

Beyond the location of the damage, several other criteria come into play. The ACL needs to be functionally intact. The lateral compartment (the outer side of the knee) should have healthy cartilage. The knee should be correctable to a normal alignment, meaning the bow-legged deformity sometimes seen in medial arthritis straightens out when the leg is not bearing weight. Inflammatory conditions like rheumatoid arthritis are exclusions. And while age itself is not an absolute barrier, the conversation about whether to pursue partial or total replacement shifts depending on a patient’s activity level and overall joint condition.

One misconception is that a patient’s weight automatically rules out partial replacement. While severe obesity does increase the mechanical demands on any implant, surgeons have expanded the body mass index thresholds over the years as data have accumulated. The decision depends more on the overall joint assessment than on a single number on the scale.

How Age Affects Outcomes

A reasonable concern for older patients is whether a partial replacement will hold up and provide enough benefit to justify the surgery. Research on patients over 80 years old undergoing Oxford UKR has shown that functional scores improve substantially after surgery, though the absolute level of function at final follow-up tends to be lower in the oldest group compared to younger patients.² In other words, an 82-year-old may not end up with the same knee function as a 62-year-old, but both experience meaningful improvement from their own baseline.

This finding makes sense intuitively. Older adults start from a lower functional baseline due to age-related muscle loss, balance changes, and often other joint problems. The surgery relieves the arthritic pain effectively, but it cannot reverse these broader aging effects. Still, the improvement in pain and daily function can be transformative for quality of life. The partial replacement’s advantage over a total replacement is arguably even more pronounced in older patients, because the smaller surgery carries less physiological stress, involves less blood loss, and typically allows a faster return to independent mobility.

At the younger end of the spectrum, surgeons sometimes hesitate to offer partial replacement because a younger patient’s knee will see more years of use, raising questions about how long the implant will last and whether a revision to a total replacement will eventually be needed. The counterargument is that preserving bone and ligaments early makes any future revision surgery simpler and more likely to succeed than revising a primary total replacement. This remains an active area of debate in orthopedic surgery.

Recovery and Early Rehabilitation

One of the selling points of the Microplasty instrumentation is the minimally invasive approach, which tends to make the first days and weeks after surgery smoother. Patients are typically allowed to bear full weight on the operated leg on the day of surgery and begin range-of-motion exercises immediately.³ The initial rehabilitation focus is on rebuilding quadriceps strength, increasing knee bend, and normalizing walking patterns. Most patients go home within two days of the operation with a home exercise program to follow.

This contrasts with total knee replacement, where weight-bearing restrictions are sometimes applied early on, and the rehabilitation arc generally takes longer because more tissue was disturbed during surgery. After a partial replacement, many people are walking without a cane within two to three weeks, and by six weeks most have recovered enough to return to desk work and light daily activities. Return to more demanding physical activities like gardening, golf, or cycling usually happens somewhere between two and four months, depending on individual progress.

That said, it would be misleading to suggest recovery is painless. The knee will be swollen and sore for several weeks, and stiffness in the morning or after prolonged sitting is common during the first few months. Some patients describe a “settling in” period where the knee gradually starts to feel like their own again. The rehabilitation exercises are not optional; skipping them is one of the most reliable ways to end up with a stiff, underperforming result regardless of how well the surgery itself went.

When Cartilage Damage Is Not Bone-on-Bone

A question that comes up in orthopedic practice is what to do when a patient has significant knee pain and cartilage damage but has not yet reached the “bone-on-bone” stage that traditionally triggers the conversation about joint replacement. This gray zone, where the cartilage is thinned but not completely gone, has historically left patients in a frustrating limbo: too damaged for conservative management to work well, but not damaged enough for a clear-cut indication for surgery.

Research into unicondylar knee arthroplasty in patients with partial-thickness cartilage loss suggests that these patients can still benefit from the procedure, though the evidence base is less established than for full-thickness loss. Functional outcomes may vary, and the decision to operate in this intermediate zone requires careful shared decision-making between surgeon and patient. The Microplasty instrumentation does not change the indication criteria itself, but the less invasive nature of the approach may lower the threshold of risk that both patient and surgeon are comfortable accepting.

Subchondroplasty and Joint-Preserving Alternatives

For patients who are not ready for any form of joint replacement, or who have painful bone marrow lesions contributing to their symptoms, a different category of procedures exists. Subchondroplasty (SCP) is one such option. Rather than replacing a joint surface, it targets painful swelling within the bone itself, called bone marrow lesions, by injecting a calcium phosphate bone substitute directly into the affected area under fluoroscopic guidance.

In a preclinical study using a canine model, subchondroplasty for post-traumatic bone marrow lesions in the femoral condyle showed an initial period of increased pain and dysfunction at three and six months, followed by symptomatic improvement that persisted up to two years. Range of motion was significantly better in the treated knees compared to untreated controls at the one- and two-year marks.⁴ The initial worsening before improvement is a pattern patients should be warned about, because it is easy to lose confidence in the procedure during those early months if expectations are not managed properly.

Subchondroplasty is not a replacement for joint replacement. It is better understood as a bridge treatment or as an option for patients whose primary source of pain is the bone marrow lesion rather than widespread cartilage loss. When the arthritis is advanced across a compartment, filling a bone marrow lesion will not address the fundamental problem. But for the right patient, it can delay or sometimes prevent the need for more invasive surgery.

Subchondroplasty Beyond the Knee

Although the knee is where subchondroplasty was first applied and remains most studied, the concept has expanded to other joints. The ankle and hindfoot present a particularly interesting application. Bone marrow lesions in the talus, often associated with osteochondral lesions or stress fractures, cause significant pain and disability and have historically been difficult to manage conservatively.

Early imaging data from a series of patients who underwent subchondroplasty in the ankle and hindfoot showed promising results. Among patients who had both pre- and post-operative MRI, the bone marrow lesions decreased in size on follow-up imaging. The majority of these procedures were performed for symptomatic bone marrow lesions linked to osteochondral lesions of the talus.⁵

When subchondroplasty of the talus was combined with bone marrow aspirate concentrate (a biologic treatment where cells from the patient’s own bone marrow are concentrated and injected alongside the filler), pain scores improved dramatically. In one small series, the average pain score on a 10-point scale dropped from about 7.8 before surgery to 0.5 at final follow-up, and overall foot and ankle function scores rose substantially. Every patient in that group said they would have the procedure again.⁶ These are very small patient numbers with short follow-up, so the results should be read as encouraging early signals rather than definitive evidence. Larger studies with longer tracking periods are needed before subchondroplasty in the ankle can be considered standard of care.

How These Procedures Fit Together

It helps to think of microplasty instrumentation for Oxford UKR and subchondroplasty as occupying different rungs on a treatment ladder. At the bottom of the ladder, you have conservative measures: physical therapy, weight management, bracing, injections. When these stop working and the source of pain is a bone marrow lesion rather than end-stage cartilage loss, subchondroplasty may buy time. When the cartilage in one compartment is severely damaged or gone, and the rest of the knee is healthy, partial replacement with the Microplasty system becomes the conversation. And when the arthritis has spread across the joint, total knee replacement moves to the front.

The decision about where a particular patient falls on this ladder is not always straightforward, and it is not always linear. Some patients who seem like good candidates for partial replacement on imaging turn out to have more extensive damage once the surgeon looks inside the joint. Others who appear to have widespread disease on X-ray actually have most of their damage localized in a way that makes a partial replacement feasible. This is one reason why surgeon experience with the Oxford system and the Microplasty instruments matters. A surgeon who has done hundreds of these procedures has a more refined sense of who will do well than one who does a handful per year.

Navigating Terminology and Expectations

The language around knee procedures can be confusing. “Microplasty” sounds like it could mean any tiny surgical repair, and patients sometimes conflate it with microfracture (a different technique where small holes are drilled into bone to stimulate cartilage repair) or with minimally invasive surgery in general. The Microplasty label is proprietary, referring specifically to the instrument set for the Oxford UKR. If your surgeon mentions microplasty, they are talking about a partial knee replacement performed with this particular system.

Similarly, “subchondroplasty” is sometimes confused with “chondroplasty,” which refers to smoothing or trimming damaged cartilage during an arthroscopy. Subchondroplasty targets the bone beneath the cartilage, not the cartilage surface itself. These are different procedures addressing different parts of the problem, and mixing them up can lead to mismatched expectations about what the surgery will accomplish.

Patients researching their options online will also encounter the term “unicompartmental” spelled and abbreviated in various ways: UKA, UKR, partial knee, uni. These all refer to the same basic concept of replacing one compartment of the knee. The Oxford system is one design among several (others include fixed-bearing designs from different manufacturers), and the Microplasty instrumentation is specific to the Oxford version. Asking your surgeon which implant system they use and why they prefer it for your particular knee is a reasonable and important question.

What the Long-Term Data Show and Where Gaps Remain

The Oxford UKR has some of the longest follow-up data of any partial knee replacement design, with registry studies tracking outcomes over 20 years in some cohorts. The implant survival rates at 10 and 15 years are generally strong when the surgery is performed on well-selected patients by experienced surgeons. However, the Microplasty instrumentation is newer than the implant itself, so the very long-term data on outcomes specifically achieved with this instrument set (as opposed to the older instrumentation) are still accumulating. Early and mid-term results have been encouraging, but it will take more time before we know whether the improved surgical precision translates to better implant survival at the 15- and 20-year marks.

For subchondroplasty, the evidence base is considerably thinner. Most published studies are small case series or preclinical work, and the procedure has not been subjected to the kind of large randomized trials that would establish it firmly in treatment guidelines. The early results are positive enough to justify continued study, but any patient considering subchondroplasty should understand that the level of evidence supporting it is substantially lower than what backs established procedures like unicompartmental or total knee replacement. That does not mean it is ineffective, only that the confidence level in outcomes predictions is lower, and there is more uncertainty about which patients will benefit most.